Ensign Peak Advisors, Inc Tarsus Pharmaceuticals, Inc. Transaction History
Ensign Peak Advisors, Inc
- $51.2 Billion
- Q1 2025
A detailed history of Ensign Peak Advisors, Inc transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 487,310 shares of TARS stock, worth $20.2 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
487,310
Previous 570,056
14.52%
Holding current value
$20.2 Million
Previous $31.6 Million
20.69%
% of portfolio
0.05%
Previous 0.06%
Shares
8 transactions
Others Institutions Holding TARS
# of Institutions
199Shares Held
44.1MCall Options Held
19.9KPut Options Held
7.6K-
Rtw Investments, LP New York, NY3.32MShares$138 Million2.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$136 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.61MShares$108 Million6.87% of portfolio
-
Jennison Associates LLC2.49MShares$103 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$102 Million8.19% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.11B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...